Back to Journals » OncoTargets and Therapy » Volume 13

Sustained Remission of Relapsed or Refractory Mantle Cell Lymphoma After 4-1BB-Based CD19-Directed CAR-T Therapy

Total article views   HTML views PDF downloads Totals
4,411 Dovepress* 3,805+ 755 4,560
PubMed Central* 606 175 781
Totals 4,411 930 5,341
*Since 25 November 2020
Total mentioned Facebook Delicious Reddit Twitter Others
6 0 0 0 3 3

View citations on PubMed Central and Google Scholar